pediatric dermatology
When Interferon Interferes: Updates in Childhood Connective Tissue Disease
Dr. Vikash Oza presented information about the diagnosis and treatment of children with connective tissue diseases, including juvenile dermatomyositis (JDM) and chronic cutaneous lupus (CCL). In multidisciplinary settings, dermatologists play an important role in the early identification, treatment, and monitoring of systemic diseases with cutaneous manifestations. Treatment for refractory skin disease in the setting of…
Latest Breakthroughs in Vascular Anomalies
Dr. Erin Mathes shared updates in the evaluation and treatment of vascular anomalies, including infantile hemangioma (IH) and port wine birthmarks (PWB). First, Mathes reviewed the clinical practice guidelines for managing IH. High-risk patients should be referred to a hemangioma specialist. The optimal referral age is 4 weeks. Mathes suggested that clinicians adjust their treatment…
Intriguing Neonatal Cases
Dr. Erin Mathes presented cases that demonstrate neonatal cutaneous processes, including erythroderma, infantile hemangiomas (IH) in preterm infants, solitary infantile myofibromas (IM), infantile malignancies, transverse nasal root veins, and newborn telangiectasias. She highlighted clinical practice gaps and areas for future research. First, Mathes discussed neonatal erythroderma. The differential diagnosis ranges from life-threatening diseases (e.g., severe…
What’s New in Pediatric Dermatology?
Dr. Chiu presented several cases to display what’s new in pediatric dermatology.